Search
for
Sort by
Research 301–330 of 1000+
- Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications
- Follikelhormone
- N-(3,5-Dimethylphenyl)-3-Methoxybenzamide (A3B5) Targets TRP-2 and Inhibits Melanogenesis and Melanoma Growth
- Exosomal miR-222-3p derived from dermal papilla cells inhibits melanogenesis in melanocytes by targeting SOX10 in rabbits
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions
- Deucravacitinib in dermatology: current indication and existing off-label data
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Discoid lupus erythematosus successfully treated with deucravacitinib
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Review of Promising Off-Label Use of Deucravacitinib
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- “PRIDE” Complex
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Alopecia universalis successfully treated with tofacitinib
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Application of Baricitinib in Dermatology
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Answer
- mTOR signaling in hair follicle and hair diseases: recent progress
- Baricitinib as a treatment for myasthenia gravis: A case report
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Targeting of Smoothened for therapeutic gain